Израиль -
иврит -
Ministry of Health
לוריאל פרופשיונל סרי אקספרט דנסיטי אדבנסד שמפו לשיער שברירי ועדין
אינטרביוטי קוסמטיקס ישראל בעמ - חפיפת שיער
Израиль -
иврит -
Ministry of Health
דואודופה
abbvie biopharmaceuticals ltd, israel - carbidopa as monohydrate; levodopa - ג'ל - levodopa 20 mg/ml; carbidopa as monohydrate 5 mg/ml - levodopa
Израиль -
иврит -
Ministry of Health
פרבליפ 10
unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 10 mg - pravastatin
Израиль -
иврит -
Ministry of Health
פולבסטרנט סנדוז
novartis israel ltd - fulvestrant - תמיסה להזרקה - fulvestrant 50 mg/ml - fulvestrant
Израиль -
иврит -
Ministry of Health
ספזמקס 30
tec-o-pharm-libra ltd - trospium chloride - טבליות מצופות פילם - trospium chloride 30 mg - trospium and analgesics - trospium and analgesics - for the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence.
Израиль -
иврит -
Ministry of Health
מוטיליום
j-c health care ltd - domperidone - טבליה - domperidone 10 mg - domperidone - domperidone - dyspeptic complaints associated with slow gastric evacuation or esophageal reflux such as epigastric sense of fullness, feeling of abdominal distention, upper abdominal pain, eructation, flatulence, nausea and vomiting, heartburn, with or without regurgitation of gastric contents into the mouth. nausea, vomiting and hiccups of various origin such as functional, organic, infectious, dietetic, following radiotherapy or as a result of drug therapy, in particular when induced by dopamine agonists like in parkinson's disease.
Израиль -
иврит -
Ministry of Health
אוויסטה
eli lilly israel ltd, israel - raloxifene hydrochloride - טבליות מצופות פילם - raloxifene hydrochloride 60 mg - raloxifene - raloxifene - evista is indicated for the treatment of osteoporosis in post menopausal women. evista is indicated for the prevention of osteoporosis in post menopausal women . evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.